StockViz
RANKINGS
TELA Bio, Inc.
NasdaqGM:TELA
Sector
Location
Market Cap
USD 75.95 M
Share Price
USD 1.92
Avg Daily Volume
128,091
Change (1 day)
-1.54%
Change (1 year)
-57.33%
Change (YTD)
-36.42%
TELA Bio, Inc. Income Statement 2018 - 2025
This table shows the Income Statement for TELA Bio, Inc. going from 2018 until 2025. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
Inner Mongolia Baotou Steel Union Co., Ltd.
USD 0.34
600010.SS
-0.01
-2.17%
Jafron Biomedical Co.,Ltd.
USD 3.36
300529.SZ
+0.14
4.31%
Sansure Biotech Inc.
USD 3.20
688289.SS
+0.07
2.21%
Shanghai Haohai Biological Technology Co., Ltd.
USD 3.74
6826.HK
-0.08
-2.16%
Boston Scientific Corporation
USD 106.14
BSX
-0.07
-0.07%
Danaher Corporation
USD 205.48
DHR
+2.67
1.32%
Chugai Pharmaceutical Co., Ltd.
USD 49.71
4519.T
+0.51
1.03%
Siemens Healthineers AG
USD 56.32
SHL.DE
+0.05
0.09%
MERCK Kommanditgesellschaft auf Aktien
USD 132.20
MRK.DE
-0.95
-0.72%
GE HealthCare Technologies Inc.
USD 77.61
GEHC
+0.84
1.09%
Agilent Technologies, Inc.
USD 120.18
A
-0.17
-0.14%
Terumo Corporation
USD 17.52
4543.T
-0.12
-0.67%
Sartorius Stedim Biotech S.A.
USD 205.46
DIM.PA
-0.41
-0.20%
Laboratory Corporation of America Holdings
USD 264.96
LH
-2.73
-1.02%
Natera, Inc.
USD 138.90
NTRA
-2.17
-1.54%
ICON Public Limited Company
USD 187.01
ICLR
-8.00
-4.10%
Baxter International Inc.
USD 29.22
BAX
+0.45
1.56%
Torrent Pharmaceuticals Limited
USD 41.64
TORNTPHARM.NS
+0.93
2.30%
Qiagen N.V.
USD 51.79
QGEN
+0.56
1.09%
Sysmex Corporation
USD 17.01
6869.T
-0.35
-2.02%